EyePoint Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.69%)
EyePoint Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(7.8%)
EyePoint Pharmaceuticals | 3:首次持股聲明-董事 Hassan Fred
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Hassan Fred
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 DICICCO WENDY F
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 ANDO GORAN
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Duker Jay S.
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Lurker Nancy
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 Zaderej Karen L.
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 ADAMIS ANTHONY P
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股變動聲明-高管 Elston George
EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
EyePoint Pharmaceuticals | 4:持股變動聲明-股東 Cormorant Asset Management, LP
EyePoint Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%)等
EyePoint Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%)等
暫無數據
暫無數據